These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26292951)

  • 1. Five Patients with Medullary Thyroid Carcinoma Presenting as Asymptomatic Elevation of Carcinoembryonic Antigen Level.
    Tan KT; Tan JZ
    Ann Acad Med Singap; 2015 Jun; 44(6):226-8. PubMed ID: 26292951
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
    Martins A; Gonçalves A; Almeida T; Midões A
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of medullary thyroid cancer in the prediction of cure after thyroidectomy.
    Nien FJ; Chang TC
    J Formos Med Assoc; 2015 Sep; 114(9):793-4. PubMed ID: 23906686
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Carcinoembryonic Antigen as Initial Presenting Sign of Medullary Thyroid Carcinoma.
    Urquhart SA; Guo R; Alexander GL
    Am J Med; 2023 May; 136(5):e81-e84. PubMed ID: 36739059
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic utility of PET/CT with
    Romero-Lluch AR; Cuenca-Cuenca JI; Guerrero-Vázquez R; Martínez-Ortega AJ; Tirado-Hospital JL; Borrego-Dorado I; Navarro-González E
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2004-2013. PubMed ID: 28646462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW; Chen YK
    World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
    Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer.
    Rowe CW; Bendinelli C; McGrath S
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):340-3. PubMed ID: 27230389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
    Fugazzola L
    Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
    [No Abstract]   [Full Text] [Related]  

  • 14. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma presenting with an initial CEA elevation.
    Abraham D; Delbridge L; Clifton-Bligh R; Clifton-Bligh P; Grodski S; Robinson BG; Messina M; Sidhu S
    ANZ J Surg; 2010 Nov; 80(11):831-3. PubMed ID: 20969693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High carcinoembryonic antigen level following cancer surgery: another way to detect thyroid medullary carcinoma].
    Martinez M; Virally ML; Guillausseau-Scholer C; Vincenot M; Samuel-Lajeunesse J; Mauvais-Jarvis F; Kévorkian JP; Porokhov B; Valleur P; Guillausseau PJ
    Rev Med Interne; 2000 Oct; 21(10):897-900. PubMed ID: 11075399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcino-embryonic antigen--no help with the differential diagnosis.
    Cobben-Beld EG; Nortier JW; Kramer WL; van de Wiel A; Rodenburg CJ
    Neth J Med; 1996 Mar; 48(3):96-9. PubMed ID: 8935750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis.
    Magis AT; Rappaport N; Conomos MP; Omenn GS; Lovejoy JC; Hood L; Price ND
    Sci Rep; 2020 Oct; 10(1):16275. PubMed ID: 33004987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Tumors of the Thyroid and Their Mimics.
    Livolsi VA
    Endocr Pathol; 2021 Jun; 32(2):211-221. PubMed ID: 33687689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased blood CEA level as initial manifestation of medullary thyroid carcinoma].
    Behr TM; Becker W
    Dtsch Med Wochenschr; 1999 Mar; 124(10):303-4. PubMed ID: 10191829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.